{"disease":{"id":"peripheral-t-cell-lymphoma-not-classified","name":"peripheral t cell lymphoma not classified"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04234048","title":"Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"SciTech Development, Inc.","has_results":false},{"nct_id":"NCT07081607","title":"Golidocitinib With Azacitidine and Chidamide in Patients With Peripheral T-cell Lymphoma.","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Ruijin Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}